Alvotech vs Opko Health
Alvotech and Opko Health are similar in size: $586m and $607m of revenue in their latest fiscal years. Alvotech grew faster (19.7% against -14.9%). Alvotech kept more of each dollar of sales as profit: a net margin of 4.8% against -37.2%.
| Latest fiscal year | AlvotechALVO, 2025 | Opko HealthOPK, 2025 |
|---|---|---|
| Revenue | $586m | $607m |
| Revenue growth | 19.7% | -14.9% |
| Net income | $27.9m | −$226m |
| Operating margin | 13.3% | -19.3% |
| Net margin | 4.8% | -37.2% |
| Return on equity | — | -17.1% |
| Free cash flow | −$115m | −$191m |
| Cash | $172m | $364m |
| Total debt | $1.30bn | $344m |
| Debt to equity | — | 27.1% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $47.0m |
| Employees | — | 2,275 |
| Market value | $1.40bn | $1.30bn |
| Price vs our value range | — | — |
| Moat score | — | 21 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 33 buys, 0 sales |